Wayland, MA, United States of America

Joe Salas

This inventor holds 9 USPTO granted patents and 13 published patent applications and 4 EPO patents. Top assignees: Bioverativ Therapeutics Inc., Biogen Ma Inc.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joe Salas. Retrieved from https://idiyas.com/inventor/joe-salas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Joe Salas: Advancing Coagulation Therapies

Introduction

Joe Salas, an innovative inventor based in Wayland, MA, is distinguished by his nine patents that focus primarily on advancing coagulation therapies. His work has significantly contributed to the fields of biochemistry and pharmaceutical research, particularly in relation to bleeding disorders.

Latest Patents

Among his latest inventions are protease-activatable procoagulant compounds. These innovative compounds comprise a procoagulant polypeptide, such as a procoagulant peptide and/or clotting factor, linked to a protease-cleavable substrate and a self-immolative spacer. When the substrate is cleaved by a protease, such as thrombin, the self-immolative spacer detaches from the polypeptide, leaving it in an active form. His work includes pharmaceutical compositions and methods to treat bleeding disorders, enhance the efficacy of procoagulant polypeptides, and even activate them when needed. Another notable patent involves chimeric clotting factors that combine an activatable clotting factor with an enhancer to improve procoagulation activities. Additionally, he has developed methods for manufacturing and utilizing these advanced clotting factors, thereby improving their pharmacokinetic properties.

Career Highlights

Joe has collaborated with notable companies such as Bioverativ Therapeutics Inc. and Biogen MA Inc., where he has applied his expertise to real-world challenges in coagulation therapies. His patent portfolio reflects a commitment to innovation in medicine and a profound impact on patient care.

Collaborations

Throughout his career, Joe has worked alongside prominent professionals in the field, including Robert T. Peters and Vu Phong Hong. This collaboration has enriched his research and development in coagulation therapies, fostering an environment of shared knowledge and innovation.

Conclusion

With a focus on enhancing therapies for bleeding disorders, Joe Salas continues to push the boundaries of innovation in the biomedical field. His contributions through his patents and collaborations lend significant advancements to treatment methodologies, positioning him as a key figure in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…